▶ 調査レポート

低分子キナーゼ阻害剤のアメリカ市場2017

• 英文タイトル:United States Small Molecule Kinase Inhibitor Market Report 2017

QYResearchが調査・発行した産業分析レポートです。低分子キナーゼ阻害剤のアメリカ市場2017 / United States Small Molecule Kinase Inhibitor Market Report 2017 / A042121724資料のイメージです。• レポートコード:A042121724
• 出版社/出版日:QYResearch / 2017年3月3日
• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥421,800 (USD3,800)▷ お問い合わせ
  Enterprise¥843,600 (USD7,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、低分子キナーゼ阻害剤のアメリカ市場について調査・分析し、低分子キナーゼ阻害剤のアメリカ市場概観、低分子キナーゼ阻害剤の種類別市場分析、用途別市場分析、低分子キナーゼ阻害剤のアメリカ市場規模予測、関連企業分析、関連企業情報、価格情報、販売動向、アメリカ市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・低分子キナーゼ阻害剤のアメリカ市場概観
・低分子キナーゼ阻害剤の種類別市場規模
・低分子キナーゼ阻害剤の用途別市場規模
・低分子キナーゼ阻害剤のアメリカ市場規模
・低分子キナーゼ阻害剤のアメリカ市場予測
・低分子キナーゼ阻害剤の製造メーカー分析
・低分子キナーゼ阻害剤のメーカー別生産量
・低分子キナーゼ阻害剤のメーカー別市場シェア
・低分子キナーゼ阻害剤の価格動向・価格分析
・低分子キナーゼ阻害剤の販売(売上高)動向
・低分子キナーゼ阻害剤の貿易(輸出・輸入)動向
・低分子キナーゼ阻害剤の産業チェーン分析
・低分子キナーゼ阻害剤のマーケティング戦略分析
・低分子キナーゼ阻害剤の販売業者(代理店)リスト
・低分子キナーゼ阻害剤の市場環境分析
...

Notes:Sales, means the sales volume of Small Molecule Kinase Inhibitor
Revenue, means the sales value of Small Molecule Kinase Inhibitor

This report studies sales (consumption) of Small Molecule Kinase Inhibitor in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Bristol-Myers Squibb
Amgen Inc.
Onyx Pharmaceuticals
Wyeth
Pfizer
Bayer Schering Pharma
Roche
AstraZeneca
Novartis
Genentech
OSI Pharmaceuticals
GlaxoSmithKline
Merck & Co.
Celgene Corporation
Sanofi Aventis
KAI Pharmaceuticals

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Small Molecule Kinase Inhibitor in each application, can be divided into
Oncology Diseases
Non-Oncology Diseases

レポート目次

Table of Contents

United States Small Molecule Kinase Inhibitor Market Report 2017
1 Small Molecule Kinase Inhibitor Overview
1.1 Product Overview and Scope of Small Molecule Kinase Inhibitor
1.2 Classification of Small Molecule Kinase Inhibitor
1.2.1 Type I
1.2.2 Type II
1.3 Application of Small Molecule Kinase Inhibitor
1.3.1 Oncology Diseases
1.3.2 Non-Oncology Diseases
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Small Molecule Kinase Inhibitor (2012-2022)
1.4.1 United States Small Molecule Kinase Inhibitor Sales and Growth Rate (2012-2022)
1.4.2 United States Small Molecule Kinase Inhibitor Revenue and Growth Rate (2012-2022)

2 United States Small Molecule Kinase Inhibitor Competition by Manufacturers
2.1 United States Small Molecule Kinase Inhibitor Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Small Molecule Kinase Inhibitor Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Small Molecule Kinase Inhibitor Average Price by Manufactures (2015 and 2016)
2.4 Small Molecule Kinase Inhibitor Market Competitive Situation and Trends
2.4.1 Small Molecule Kinase Inhibitor Market Concentration Rate
2.4.2 Small Molecule Kinase Inhibitor Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Small Molecule Kinase Inhibitor Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Small Molecule Kinase Inhibitor Sales and Market Share by States (2012-2017)
3.2 United States Small Molecule Kinase Inhibitor Revenue and Market Share by States (2012-2017)
3.3 United States Small Molecule Kinase Inhibitor Price by States (2012-2017)

4 United States Small Molecule Kinase Inhibitor Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Small Molecule Kinase Inhibitor Sales and Market Share by Type (2012-2017)
4.2 United States Small Molecule Kinase Inhibitor Revenue and Market Share by Type (2012-2017)
4.3 United States Small Molecule Kinase Inhibitor Price by Type (2012-2017)
4.4 United States Small Molecule Kinase Inhibitor Sales Growth Rate by Type (2012-2017)

5 United States Small Molecule Kinase Inhibitor Sales (Volume) by Application (2012-2017)
5.1 United States Small Molecule Kinase Inhibitor Sales and Market Share by Application (2012-2017)
5.2 United States Small Molecule Kinase Inhibitor Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Small Molecule Kinase Inhibitor Manufacturers Profiles/Analysis
6.1 Bristol-Myers Squibb
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Small Molecule Kinase Inhibitor Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Bristol-Myers Squibb Small Molecule Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Amgen Inc.
6.2.2 Small Molecule Kinase Inhibitor Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Amgen Inc. Small Molecule Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Onyx Pharmaceuticals
6.3.2 Small Molecule Kinase Inhibitor Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Onyx Pharmaceuticals Small Molecule Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Wyeth
6.4.2 Small Molecule Kinase Inhibitor Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Wyeth Small Molecule Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Pfizer
6.5.2 Small Molecule Kinase Inhibitor Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Pfizer Small Molecule Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Bayer Schering Pharma
6.6.2 Small Molecule Kinase Inhibitor Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Bayer Schering Pharma Small Molecule Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Roche
6.7.2 Small Molecule Kinase Inhibitor Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Roche Small Molecule Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 AstraZeneca
6.8.2 Small Molecule Kinase Inhibitor Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 AstraZeneca Small Molecule Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Novartis
6.9.2 Small Molecule Kinase Inhibitor Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Novartis Small Molecule Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Genentech
6.10.2 Small Molecule Kinase Inhibitor Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Genentech Small Molecule Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 OSI Pharmaceuticals
6.12 GlaxoSmithKline
6.13 Merck & Co.
6.14 Celgene Corporation
6.15 Sanofi Aventis
6.16 KAI Pharmaceuticals

7 Small Molecule Kinase Inhibitor Manufacturing Cost Analysis
7.1 Small Molecule Kinase Inhibitor Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Small Molecule Kinase Inhibitor

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Small Molecule Kinase Inhibitor Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Small Molecule Kinase Inhibitor Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Small Molecule Kinase Inhibitor Market Forecast (2017-2022)
11.1 United States Small Molecule Kinase Inhibitor Sales, Revenue Forecast (2017-2022)
11.2 United States Small Molecule Kinase Inhibitor Sales Forecast by Type (2017-2022)
11.3 United States Small Molecule Kinase Inhibitor Sales Forecast by Application (2017-2022)
11.4 Small Molecule Kinase Inhibitor Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Small Molecule Kinase Inhibitor
Table Classification of Small Molecule Kinase Inhibitor
Figure United States Sales Market Share of Small Molecule Kinase Inhibitor by Type in 2015
Table Application of Small Molecule Kinase Inhibitor
Figure United States Sales Market Share of Small Molecule Kinase Inhibitor by Application in 2015
Figure Oncology Diseases Examples
Figure Non-Oncology Diseases Examples
Figure United States Small Molecule Kinase Inhibitor Sales and Growth Rate (2012-2022)
Figure United States Small Molecule Kinase Inhibitor Revenue and Growth Rate (2012-2022)
Table United States Small Molecule Kinase Inhibitor Sales of Key Manufacturers (2015 and 2016)
Table United States Small Molecule Kinase Inhibitor Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Small Molecule Kinase Inhibitor Sales Share by Manufacturers
Figure 2016 Small Molecule Kinase Inhibitor Sales Share by Manufacturers
Table United States Small Molecule Kinase Inhibitor Revenue by Manufacturers (2015 and 2016)
Table United States Small Molecule Kinase Inhibitor Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Small Molecule Kinase Inhibitor Revenue Share by Manufacturers
Table 2016 United States Small Molecule Kinase Inhibitor Revenue Share by Manufacturers
Table United States Market Small Molecule Kinase Inhibitor Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Small Molecule Kinase Inhibitor Average Price of Key Manufacturers in 2015
Figure Small Molecule Kinase Inhibitor Market Share of Top 3 Manufacturers
Figure Small Molecule Kinase Inhibitor Market Share of Top 5 Manufacturers
Table United States Small Molecule Kinase Inhibitor Sales by States (2012-2017)
Table United States Small Molecule Kinase Inhibitor Sales Share by States (2012-2017)
Figure United States Small Molecule Kinase Inhibitor Sales Market Share by States in 2015
Table United States Small Molecule Kinase Inhibitor Revenue and Market Share by States (2012-2017)
Table United States Small Molecule Kinase Inhibitor Revenue Share by States (2012-2017)
Figure Revenue Market Share of Small Molecule Kinase Inhibitor by States (2012-2017)
Table United States Small Molecule Kinase Inhibitor Price by States (2012-2017)
Table United States Small Molecule Kinase Inhibitor Sales by Type (2012-2017)
Table United States Small Molecule Kinase Inhibitor Sales Share by Type (2012-2017)
Figure United States Small Molecule Kinase Inhibitor Sales Market Share by Type in 2015
Table United States Small Molecule Kinase Inhibitor Revenue and Market Share by Type (2012-2017)
Table United States Small Molecule Kinase Inhibitor Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Small Molecule Kinase Inhibitor by Type (2012-2017)
Table United States Small Molecule Kinase Inhibitor Price by Type (2012-2017)
Figure United States Small Molecule Kinase Inhibitor Sales Growth Rate by Type (2012-2017)
Table United States Small Molecule Kinase Inhibitor Sales by Application (2012-2017)
Table United States Small Molecule Kinase Inhibitor Sales Market Share by Application (2012-2017)
Figure United States Small Molecule Kinase Inhibitor Sales Market Share by Application in 2015
Table United States Small Molecule Kinase Inhibitor Sales Growth Rate by Application (2012-2017)
Figure United States Small Molecule Kinase Inhibitor Sales Growth Rate by Application (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Small Molecule Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Small Molecule Kinase Inhibitor Sales Market Share (2012-2017)
Table Amgen Inc. Basic Information List
Table Amgen Inc. Small Molecule Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Inc. Small Molecule Kinase Inhibitor Sales Market Share (2012-2017)
Table Onyx Pharmaceuticals Basic Information List
Table Onyx Pharmaceuticals Small Molecule Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table Onyx Pharmaceuticals Small Molecule Kinase Inhibitor Sales Market Share (2012-2017)
Table Wyeth Basic Information List
Table Wyeth Small Molecule Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table Wyeth Small Molecule Kinase Inhibitor Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Small Molecule Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Small Molecule Kinase Inhibitor Sales Market Share (2012-2017)
Table Bayer Schering Pharma Basic Information List
Table Bayer Schering Pharma Small Molecule Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Schering Pharma Small Molecule Kinase Inhibitor Sales Market Share (2012-2017)
Table Roche Basic Information List
Table Roche Small Molecule Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table Roche Small Molecule Kinase Inhibitor Sales Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Small Molecule Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Small Molecule Kinase Inhibitor Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Small Molecule Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Small Molecule Kinase Inhibitor Sales Market Share (2012-2017)
Table Genentech Basic Information List
Table Genentech Small Molecule Kinase Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Table Genentech Small Molecule Kinase Inhibitor Sales Market Share (2012-2017)
Table OSI Pharmaceuticals Basic Information List
Table GlaxoSmithKline Basic Information List
Table Merck & Co. Basic Information List
Table Celgene Corporation Basic Information List
Table Sanofi Aventis Basic Information List
Table KAI Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Small Molecule Kinase Inhibitor
Figure Manufacturing Process Analysis of Small Molecule Kinase Inhibitor
Figure Small Molecule Kinase Inhibitor Industrial Chain Analysis
Table Raw Materials Sources of Small Molecule Kinase Inhibitor Major Manufacturers in 2015
Table Major Buyers of Small Molecule Kinase Inhibitor
Table Distributors/Traders List
Figure United States Small Molecule Kinase Inhibitor Production and Growth Rate Forecast (2017-2022)
Figure United States Small Molecule Kinase Inhibitor Revenue and Growth Rate Forecast (2017-2022)
Table United States Small Molecule Kinase Inhibitor Production Forecast by Type (2017-2022)
Table United States Small Molecule Kinase Inhibitor Consumption Forecast by Application (2017-2022)
Table United States Small Molecule Kinase Inhibitor Sales Forecast by States (2017-2022)
Table United States Small Molecule Kinase Inhibitor Sales Share Forecast by States (2017-2022)